My Account

Pharmacy Checker’s Legal Battle Against Big Pharma

Pharmacy Checker has filed a lawsuit accusing major pharmaceutical entities, including NABP, ASOP, CSIP, Legit Script LLC, and PSM, of using shadow regulation tactics. These tactics allegedly manipulate consumer access to crucial information about cost-effective medications from online foreign pharmacies for U.S. residents. The lawsuit claims these organizations leverage their relationships with internet gatekeepers to blacklist legitimate Canadian and other foreign pharmacies, as well as This practice is purportedly aimed at restricting access to essential online medication details, maintaining a monopoly, and inflating U.S. drug prices.

Impact on Consumer Access and Drug Prices

The lawsuit highlights how these alleged regulatory practices hinder consumer awareness and access to more affordable prescription options. Many U.S. residents may not realize that reputable international pharmacies offer brand-name medications and dermal fillers at prices significantly lower—often up to 90% less—than those charged by U.S. pharmacies. This lack of transparency perpetuates higher drug costs domestically.

Monopoly Concerns and Market Manipulation

Pharmacy Checker’s legal action underscores concerns about monopolistic practices within the pharmaceutical industry. By allegedly controlling access to information through regulatory maneuvers, the accused entities purportedly monopolize the market for online medication sales. This control not only limits consumer choice but also potentially restricts competition that could lower drug prices in the U.S. market.

Allegations and Regulatory Influence

The lawsuit alleges that the NABP, ASOP, CSIP, Legit Script LLC, and PSM engage in shadow regulation practices. This term refers to non-governmental entities influencing online platforms to enforce their policies outside traditional regulatory frameworks. Such practices include blacklisting legitimate foreign pharmacies and online resources like, effectively controlling what information consumers can access about international medication options.

Influence on Internet Gatekeepers

Central to the lawsuit’s claims is the accused entities’ purported manipulation of relationships with internet gatekeepers. These gatekeepers, such as search engines and domain registrars, play pivotal roles in controlling online visibility and accessibility. Pharmacy Checker asserts that these entities leverage these relationships to enforce restrictions that limit competition from foreign pharmacies, thereby maintaining higher drug prices in the U.S.

Importance of Consumer Awareness

Educating Consumers on Affordable Alternatives

Amidst these legal developments, Medica Depot emphasizes the importance of consumer education. Many individuals remain unaware of the substantial cost savings available through reputable international pharmacies. Heightened awareness of these options could empower consumers to explore more affordable avenues for prescription medications and dermal fillers.

Support for Transparency and Access

Medica Depot stands behind initiatives that promote transparency and accessibility in the pharmaceutical market. By advocating for informed consumer choices and challenging alleged monopolistic practices, the company supports efforts that could potentially lower drug costs and expand access to affordable healthcare options.

Looking Ahead: Implications for Future Healthcare Policy

The outcome of Pharmacy Checker’s lawsuit could have far-reaching implications for healthcare policy and consumer rights. A favorable resolution may lead to greater transparency in the pharmaceutical industry, fostering competition and potentially lowering drug prices. Conversely, a lack of regulation over alleged shadow practices could perpetuate market monopolization and hinder efforts to make healthcare more affordable for U.S. consumers.

Continued Advocacy for Consumer Rights

As the legal battle unfolds, Medica Depot remains committed to advocating for consumer rights and access to affordable medications. By staying informed and supporting initiatives that promote fair market practices, the company aims to contribute to a healthcare landscape where patient needs and affordability are prioritized.

Our website is intended solely for people who use medical devices, such as dermal fillers, as professionals. It may contain product advertisements targeted only at such people. To enter Nu Derma Supply, please confirm that you are such a person (e.g. a medical professional, cosmetologist, service technician, etc.).